A detailed history of Nbc Securities, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Nbc Securities, Inc. holds 1 shares of TGTX stock, worth $29. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1,309 99.92%
Holding current value
$29
Previous $30,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

SELL
$21.31 - $35.09 $27,873 - $45,897
-1,308 Reduced 99.92%
1 $39,000
Q3 2024

Oct 15, 2024

BUY
$17.21 - $25.28 $8,346 - $12,260
485 Added 58.86%
1,309 $30,000
Q1 2024

Apr 05, 2024

SELL
$13.02 - $21.3 $111,672 - $182,690
-8,577 Reduced 91.23%
824 $12,000
Q4 2023

Feb 07, 2024

BUY
$6.68 - $18.81 $16,092 - $45,313
2,409 Added 34.45%
9,401 $160,000
Q3 2023

Nov 03, 2023

BUY
$8.36 - $26.5 $58,453 - $185,288
6,992 New
6,992 $58,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.